318 related articles for article (PubMed ID: 15548371)
1. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays.
Grützmann R; Pilarsky C; Ammerpohl O; Lüttges J; Böhme A; Sipos B; Foerder M; Alldinger I; Jahnke B; Schackert HK; Kalthoff H; Kremer B; Klöppel G; Saeger HD
Neoplasia; 2004; 6(5):611-22. PubMed ID: 15548371
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles of microdissected pancreatic ductal adenocarcinoma.
Grützmann R; Foerder M; Alldinger I; Staub E; Brümmendorf T; Röpcke S; Li X; Kristiansen G; Jesenofsky R; Sipos B; Löhr M; Lüttges J; Ockert D; Klöppel G; Saeger HD; Pilarsky C
Virchows Arch; 2003 Oct; 443(4):508-17. PubMed ID: 12942322
[TBL] [Abstract][Full Text] [Related]
3. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
4. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
[TBL] [Abstract][Full Text] [Related]
5. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells.
Prasad NB; Biankin AV; Fukushima N; Maitra A; Dhara S; Elkahloun AG; Hruban RH; Goggins M; Leach SD
Cancer Res; 2005 Mar; 65(5):1619-26. PubMed ID: 15753353
[TBL] [Abstract][Full Text] [Related]
7. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
[TBL] [Abstract][Full Text] [Related]
9. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
10. Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma.
Fukushima N; Koopmann J; Sato N; Prasad N; Carvalho R; Leach SD; Hruban RH; Goggins M
Mod Pathol; 2005 Jun; 18(6):779-87. PubMed ID: 15791284
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of IMP3 in microdissected premalignant and malignant pancreatic lesions.
Wang BJ; Wang L; Yang SY; Liu ZJ
Clin Transl Oncol; 2015 Mar; 17(3):215-22. PubMed ID: 25183049
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays.
Harada T; Chelala C; Bhakta V; Chaplin T; Caulee K; Baril P; Young BD; Lemoine NR
Oncogene; 2008 Mar; 27(13):1951-60. PubMed ID: 17952125
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling.
Hirono S; Yamaue H; Hoshikawa Y; Ina S; Tani M; Kawai M; Ushijima M; Matsuura M; Saiki Y; Saiura A; Yamamoto J; Miki Y; Noda T
Cancer Sci; 2010 Jan; 101(1):259-66. PubMed ID: 19817750
[TBL] [Abstract][Full Text] [Related]
14. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2.
Inaguma S; Ito H; Riku M; Ikeda H; Kasai K
Oncotarget; 2015 Sep; 6(29):28257-68. PubMed ID: 26318045
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
[TBL] [Abstract][Full Text] [Related]
16. Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling.
Pilarsky C; Ammerpohl O; Sipos B; Dahl E; Hartmann A; Wellmann A; Braunschweig T; Löhr M; Jesenofsky R; Friess H; Wente MN; Kristiansen G; Jahnke B; Denz A; Rückert F; Schackert HK; Klöppel G; Kalthoff H; Saeger HD; Grützmann R
J Cell Mol Med; 2008 Dec; 12(6B):2823-35. PubMed ID: 18298655
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of gene expression profiles reveals specific signaling pathways associated with pancreatic duct adenocarcinoma.
Li J; Tan W; Peng L; Zhang J; Huang X; Cui Q; Zheng J; Tan W; Wu C; Lin D
Cancer Commun (Lond); 2018 Apr; 38(1):13. PubMed ID: 29764514
[TBL] [Abstract][Full Text] [Related]
18. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
[TBL] [Abstract][Full Text] [Related]
19. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma.
Gao W; Zhou Y; Li Q; Zhou Q; Tan L; Song Y; Zhao X; Yu M; Zheng S; Ye H; Zeng B; Lin Q; Zhou J; Liu Y; Huang H; Zhang H; Hu X; Li Z; Dai X; Chen R
Diabetologia; 2015 Apr; 58(4):835-44. PubMed ID: 25636208
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma.
Riener MO; Pilarsky C; Gerhardt J; Grützmann R; Fritzsche FR; Bahra M; Weichert W; Kristiansen G
Histol Histopathol; 2009 Sep; 24(9):1121-8. PubMed ID: 19609859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
